ID   UOK360
AC   CVCL_B3PR
DR   Wikidata; Q110433950
RX   PubMed=32259323;
CC   Population: African American.
CC   Doubling time: ~24 hours (PubMed=32259323).
CC   Karyotypic information: Hypertriploid karyotype (PubMed=32259323).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Ser258Valfs*23 (c.771insA); Zygosity=Homozygous (PubMed=32259323).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=32259323; DOI=10.1002/gcc.22847; PMCID=PMC7383978;
RA   Wei D., Yang Y.-F., Ricketts C.J., Vocke C.D., Ball M.W., Sourbier C.,
RA   Wangsa Zong D., Wangsa D., Guha R., Zhang X.-H., Wilson K.M., Chen L.,
RA   Meltzer P.S., Ried T., Thomas C.J., Merino M.J., Linehan W.M.;
RT   "Novel renal medullary carcinoma cell lines, UOK353 and UOK360,
RT   provide preclinical tools to identify new therapeutic treatments.";
RL   Genes Chromosomes Cancer 59:472-483(2020).
//